Partnering News

09.09.2011

Lpath Initiates Dosing of iSONEP in First of Two Proof-ofConcept Trials

08.29.2011

Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components

08.16.2011

QIAGEN and Pfizer partner to develop companion diagnostic for novel compound in global clinical trials for lung Cancer

08.03.2011

Biotica regains worldwide rights to its rapamycin analogue program

07.07.2011

Pfizer To Explore Strategic Alternatives For Its Animal Health And Nutrition Businesses

07.05.2011

A prototype Handheld Device that Analyses DNA to Predict How Patients May Respond to their Prescription Medication has Performed Well in a Preliminary Pilot Study, Researchers Announce Today.

07.05.2011

Cell Signaling Technology, Inc. Grants a Patent License to Pfizer

06.14.2011

pSivida Announces Phase I/II Clinical Study Evaluating Bioerodible, Sustained Release Latanoprost Device in Ocular Hypertension and Glaucoma

06.09.2011

Lpath Granted 22nd Patent Related to Lipidomics-Based Drug Development Program

06.02.2011

Pfizer and Hisun Sign MOU to Increase Access to Quality and Low-Cost Medicines for Patients in China

06.02.2011

Clovis Oncology, Inc. Receives License for Worldwide Development and Commercialization Rights to Pfizer’s Oral and IV PARP Inhibitor PF-01367338

05.10.2011

Foundation for the NIH Launches Trial to Develop Diabetes Diagnostic Tools